The Centre For Doctoral Training (CDT) in The EPSRC Centre For Innovative Manufacturing In Emergent Macromolecular Therapies was established in May 2012. Its focus will be on manufacturing research and training required in the most rapidly developing parts of the UK bio-centred pharmaceutical and healthcare biotechnology sector, that have major implications for future medicine.
Our aim is to train bioprocess engineering leaders of the future who will underpin translation of new scientific advances into safely produced, more selective, therapies for currently intractable conditions at affordable costs. To achieve this we will embed CDT PhDs within the vibrant research community of the top UK Institutions and that of the EPSRC Centre for Innovative Manufacturing in Emergent Macromolecular Therapies, to ensure that they benefit in terms of impact and knowledge transfer from the links to research led companies.
It is essential that we are able to capture novel analytical, mathematical, computational and predictive techniques, emerging from academic laboratories across the UK to bring them to bear on our EPSRC Centre vision. We will support CDT PhDs to establish blue-sky collaborations with academics whose underpinning research areas will in time directly bear upon bioprocess manufacturing. At least 75% of the CDT cohort will be based at highly resourced external collaborating Institutes. 15 PhDs will be funded by the CDT until 2015.
To discuss potential research projects that could be supported by the CDT please contact Dr Paul Dalby.